Sugentech Inc. (KOSDAQ: 253840)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,770.00
-70.00 (-1.20%)
Oct 11, 2024, 1:27 PM KST

Sugentech Company Description

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally.

The company offers Multiplex BLOT disease diagnostic devices, such as immunoblot processor, semi and full automation, and molecular diagnostic systems, as well as test items; and self-testing products, including digital ovulation, pregnancy test, and early sign pregnancy test, as well as mobile testing products.

It also provides point of care testing analyzers and test items for testing of M.tuberculosis, M.bovis, SARS-CoV-2 antibodies and antigens, flu A/B antigens, and CRP/hsCRP /dualCRP, as well as for measuring procalcitonin, troponin I, hemoglobinA1c, human chorionic gonadotropin, immunoglobulin E, and influenza A/B.

The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013.

Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea.

Sugentech Inc.
Country South Korea
Founded 2011
Industry Electromedical and Electrotherapeutic Apparatus
Employees 138
CEO Jin Mi

Contact Details

Address:
206, Techno 2-ro
Daejeon, 34028
South Korea
Phone 82 4 2364 5001
Website sugentech.com

Stock Details

Ticker Symbol 253840
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3845

Key Executives

Name Position
Jin Mi Chief Executive Officer